Treatment of depression in older adults

Current Psychiatry Reports

Volumn 14, Issue 4, 2012, Pages 289-297

  Bottino, Cássio M C ^a   Barcelos Ferreira, Ricardo ^a   Ribeiz, Salma R I ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adverse effects; Aging; Antidepressants; Comorbidity; Depression; Electroconvulsive therapy; Integrated psychotherapy; Monoamine oxidase inhibitors; Older adults; Polypharmacy; Recovery; Resistance to treatment; Selective serotonin reuptake inhibitors; Serotonin and norepinephrine reuptake inhibitors; Transcranial magnetic stimulation; Treatment; Tricyclic antidepressants

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; DULOXETINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; ARTICLE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; FALLING; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPONATREMIA; INSOMNIA; MAJOR DEPRESSION; NAUSEA; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINE; SEXUAL DYSFUNCTION; SIDE EFFECT; TACHYCARDIA; TASTE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; WEIGHT CHANGE; WEIGHT GAIN; XEROSTOMIA;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; HUMANS; PSYCHOTHERAPY;

EID: 84865631858     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0281-z     Document Type: Article

References (57)

1. Blazer DG. Depression in late life: review and commentary. J Gerontol: Med Sci. 2003;58(3):249-65. (Pubitemid 36307597)
2. O'Connor DW. Do older Australians truly have low rates of anxiety and depression? A critique of the 1997 National Survey of Mental Health and Wellbeing. Aust New Zeal J Psychiatr. 2006;40:623-31. (Pubitemid 43984964)
3. Australian Bureau of Statistics. Mental Health and Wellbeing: Profile of Adults, Australia (No. ABS Catalogue No. 4326.0). Canberra: ABS; 1998.
4. Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of results (No. ABS Catalogue No. 4326.0). Canberra: ABS; 2008.
5. Baldwin R. Mood disorders: depressive disorders. In: Jacoby R, Oppenheimer C, Dening T, Thomas A, editors. Oxford textbook of old age psychiatry. Oxford: Oxford University Press; 2008. p. 529-56.
6. Chiu E, Ames D, Draper B, Snowdon J. Depressive disorders in the elderly: a review. In: Herrman H, Maj M, Sartorius N, editors. Depressive disorders. 3rd ed. NJ, USA: Wiley; 2009.
7. Cummings SM. Predictors of psychological well-being among assisted living residents. Heal Soc Work. 2002;27:293-302.
8. Bryant C, Jackson H, Ames D. Depression and anxiety in medically unwell older adults: prevalence of short-term course. Int Psychogeriatr. 2009;21:754-63.
9. Wells KB, Katon W, Rogers B, et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry. 1994;151:694-700. (Pubitemid 24140558)
10. Bottino CMC. The challenge of treating depression in the elderly. Int Clin Psychopharmacol. 2003;18:S39-45.
11. van Moltke LL, Abernethy DR, Greenblatt DJ. Kinetics and dynamics of psychotropic drugs in the elderly. In: Salzman C, editor. Clinical geriatric psychopharmacology. 3rd ed. Baltimore: William & Wilkins; 1998. p. 70-93.
12. Baldwin RC, Anderson D, Black S, et al. Faculty of Old Age Psychiatry Working Group, Royal College of Psychiatrists. Guideline for the management of late-life depression in primary care. Int J Geriatr Psychiatry. 2003;18:829-38. (Pubitemid 37150487)
13. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Ver. 2006;(1): CD003491.
14. Chemali Z, Chahine LM, Fricchione G. The use of selective serotonin reuptake inhibitors in elderly patients. Harv Rev Psychiatry. 2009;17:242-53.
15. Salzman C, Wong E, Wright BC. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol Psychiatry. 2002;52:265-84. (Pubitemid 35232093)
16. Weihs KL, Settle Jr. EC, Batey SR, et al. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry. 2000;61(3):196-202. (Pubitemid 30214516)
17. Nelson JC, Wohlreich MM, Mallinckrodt CH, et al. Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry. 2005;13(3):227-35. (Pubitemid 41031091)
18. Schatzberg AF, Kremer C, Rodrigues HE, et al. The Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry. 2002;10(5):541-50. (Pubitemid 34984390)
19. Staab JP, Evans DL. Efficacy of venlafaxine in geriatric depression. Depress Anxiety. 2000;12 Suppl 1:63-8.
20. Andreescu C, Reynolds 3rd CF. Late-life depression: evidence-based treatment and promising new directions for research and clinical practice. Psychiatr Clin North Am. 2011;34(2):335-55.
21. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry. 1999;156 (8):1182-9. (Pubitemid 29374877)
22. Hays JC, Steffens DC, Flint EP, et al. Does social support buffer functional decline in elderly patients with unipolar depression? Am J Psychiatry. 2001;158(11):1850-5. (Pubitemid 33054778)
23. Reynolds 3rd CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA. 1999;281(1):39-45. (Pubitemid 29025098)
24. Lenze EJ, Dew MA, Mazumdar S, et al. Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment. Am J Psychiatry. 2002;159 (3):466-8. (Pubitemid 34184744)
25. Reynolds CF, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354:1130-8.
26. Carvalho AF, Machado JR, Cavalcante JL. Augmentation strategies for treatment-resistant depression. Curr Opin Psychiatry. 2009;22(1):7-12.
27. Alexopoulos GS et al. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med. 2001; Spec No Pharmacotherapy: 1-86.
28. Alexopoulos GS, Katz IR, Bruce ML, et al. Remission in depressed geriatric primary care patients: a report from the PROSPECT Study. Am J Psychiatry. 2005;162(4):718-24. (Pubitemid 40489134)
29. Shelton RC, OO, Heinloth AN, Corya SA. Therapeutic options for treatment-resistant depression. CNS Drugs. 2010;24(2):131-161. A recent paper about therapeutic options for treatmentresistant depression.
30. Mulsant BH, et al. Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry. 2001;16(6):585-92. (Pubitemid 32618851)
31. Bauer M, Pfennig A, Linden M, Smolka MN, et al. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. J Clin Psychopharmacol. 2009;29(4):327-33.
32. Steffens DC. The Duke somatic treatment algorithm for geriatric depression (STAGED) approach. Psychopharmacol Bull. 2002;36 (2):58-68.
33. Whyte EM, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(12):1634-41.
34. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol. 1994;14(5):353-6. (Pubitemid 24316935)
35. Papakostas GI, Worthington 3rd JJ, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, et al. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depress Anxiety. 2006;23(3):178-81. (Pubitemid 43727149)
36. Favas M. Augmentation and combination strategies for complicated depression. Clin Psychiatry. 2009;70(11):40.
37. Ross J. Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review. Can J Psychiatry. 2008;53(2):117-20. (Pubitemid 351287753)
38. deBattista C. Augmentation and combination strategies for depression. J Psychopharmacol. 2006;20(3):11-8. (Pubitemid 44605928)
39. Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res. 1990;32(3):241-51. (Pubitemid 20214380)
40. Fleurence R, Williamson R, Jing Y, Kim E, Tran QV, Pikalov AS, et al. A systematic review of augmentation strategies for patients with major depressive disorder. Psychopharmacol Bull. 2009;42 (3):57-90.
41. Lavretsky H, et al. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry. 2003;64(12):1410-4. (Pubitemid 41270097)
42. Van der Wurff FB, Stek ML, Hoogendijk WL, et al. Electroconvulsive therapy for the depressed elderly. Cochrane Database Syst Rev. 2003;(2):CD003593).
43. Sienaert P. What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Can J Psychiatry. 2011;56(1):5-12.
44. Fabre I, Galinowski A, Oppenheim C, et al. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression. Int J Geriatr Psychiatry. 2004;19 (9):833-42. (Pubitemid 39242888)
45. Manes F, Jorge R, Morcuende M, et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr. 2001;13(2):225-31. (Pubitemid 32703333)
46. Mosimann UP, Schmitt W, Greenberg BD, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 2004;126(2):123-33. (Pubitemid 38581245)
47. Jorge RE, Moser DJ, Acion L, et al. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008;65(3):268-76. (Pubitemid 351342443)
48. Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care.World J Biol Psychiatry. 2007;8(2):67-104. (Pubitemid 46690921)
49. Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry. 2006;59:1029-38. (Pubitemid 43849663)
50. National Institute for Health and Clinical Excellence. Depression: management of depression in primary and secondary care. NICE; 2004.
51. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-70. (Pubitemid 30318269)
52. Friedman MA, Detweiler-Bedel JB, Leventhal HE, et al. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract. 2004;11:47-68. (Pubitemid 38735568)
53. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry. 2004;61:714-9. (Pubitemid 38890806)
54. Fava GA, Ruini C. What is the optimal treatment of mood and anxiety disorders? Clin Psychol Sci Pract. 2005;12:92-6. (Pubitemid 40309357)
55. Oestergaard S, Møldrup C. Improving outcomes for patients with depression by enhancing antidepressant therapy with nonpharmacological interventions: a systematic review of reviews. Public Health. 2011;125:357-67. Recent systematic review about combined therapy: pharmacological and non-pharmacological interventions.
56. Alexopoulos GS, Salzman C. Treatment of depression with heterocyclic antidepressants, monoamine oxidase inhibitors, and psychomotor stimulants. In: C. Salzman, editor. Clinical geriatric psychopharmacology. Baltimore: Williams & Wilkins; 1998. p. 184-244.
57. Small GW, Salzman C. Treatment of depression with new and atypical antidepressants. In: C. Salzman, editor. Clinical geriatric psychopharmacology. Baltimore: Williams & Wilkins; 1998. p. 245-61.